GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 60 filers reported holding GAMIDA CELL LTD in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $175,482 | -46.6% | 175,000 | 0.0% | 0.15% | -39.7% |
| Q2 2023 | $328,317 | +143.6% | 175,000 | 0.0% | 0.25% | +89.5% |
| Q1 2023 | $134,750 | -39.1% | 175,000 | 0.0% | 0.13% | -36.4% |
| Q4 2022 | $221,189 | -26.5% | 175,000 | 0.0% | 0.21% | -28.4% |
| Q3 2022 | $301,000 | -2.0% | 175,000 | 0.0% | 0.29% | +6.2% |
| Q2 2022 | $307,000 | -57.4% | 175,000 | 0.0% | 0.28% | -50.5% |
| Q1 2022 | $721,000 | +62.8% | 175,000 | 0.0% | 0.56% | +73.4% |
| Q4 2021 | $443,000 | -35.4% | 175,000 | 0.0% | 0.32% | -40.6% |
| Q3 2021 | $686,000 | – | 175,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |